Company / Goodwill
Boston Scientific Goodwill History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Goodwill
$18.3B
FY2025
5-year range
$10.0B / $18.3B
FY2021-FY2025
Trend
+7.0%
vs FY2024
Sector context
#10 of 136
Health Care
What the data says
Among 136 Health Care companies, Boston Scientific is in the top 7% for goodwill. Goodwill has increased for 4 consecutive years, from $10.0B in FY2021 to $18.3B in FY2025.
Based on SEC 10-K filings.
$18.3B in FY2025 with a 5-year CAGR of +12.4%. Top quartile in the Health Care sector.
Improved from $14.4B to $18.3B over the past 2 years.
Health Care sector context is included.
Goodwill over time
Growth rates
- 3-Year CAGR
- +12.3%
- 5-Year CAGR
- +12.4%
- 10-Year CAGR
- -
Sector benchmark
Top 7% in Health CareTop 7% of 136This company $18.3B Sector average $5.2B
▼
+249.0% above sector average
Key checks
Key Insights
- Boston Scientific's goodwill has grown for 4 consecutive years.
- 5-year CAGR of +12.4%, indicating consistent growth.
- In FY2025, goodwill increased 7.0% year-over-year.
- Ranks #10 out of 136 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | GoodwillValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $18.3B | +7.0% |
| FY2024 | $17.1B | +18.8% |
| FY2023 | $14.4B | +11.4% |
| FY2022 | $12.9B | +29.8% |
| FY2021 | $10.0B | -2.2% |
| FY2020 | $10.2B | +0.0% |
| FY2019 | $10.2B | +28.6% |
| FY2018 | $7.9B | +13.0% |
| FY2017 | $7.0B | +4.8% |
| FY2016 | $6.7B | +3.2% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026